Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Jan 29;8:1714. doi: 10.1038/s41598-018-20169-8

Efficient strategy for introducing large and multiple changes in plasmid DNA

Fanli Zeng 1, Suhua Zhang 2, Zhimin Hao 1, Shixin Duan 1, Yanan Meng 1, Pan Li 1, Jingao Dong 1,, Yibin Lin 3,
PMCID: PMC5789069  PMID: 29379085

Abstract

While the QuikChange site-directed mutagenesis method and its later modifications are extremely useful and simple, they suffer from several drawbacks. Here, we propose a new method, named LFEAP mutagenesis (Ligation of Fragment Ends After PCR) for creating various mutations in plasmid by leveraging three existing concepts: inverse PCR, single primer PCR, and sticky-end assembly. The first inverse PCR on the target plasmid yielded linearized DNA fragments with mutagenic ends, and a second single primer PCR resulted in complementary single-stranded DNA fragments with the addition of overhangs at the 5′ end of each strand. The resulting single strands were then annealed to produce double-stranded DNA with free 5′ single-stranded DNA tails. These products with compatible sticky ends were efficiently assembled into a circular, mutagenized plasmid. With this strategy, multiple simultaneous changes (up to 15) and mutations in large plasmids (up to 50 kb) were achieved with high efficiency and fidelity. LFEAP mutagenesis is a versatile method that offers significant advantages for introducing large and multiple changes in plasmid DNA.

Introduction

Polymerase chain reaction (PCR)-based site-directed mutagenesis is an invaluable technique for altering genes and hence the structure and activity of individual proteins in a systematic way, opening up opportunities for investigating the structure-function relationships of protein, enzyme specificity and selectivity, or protein engineering13.

In the past decade, a number of strategies and commercial kits have been developed for introducing mutational changes in plasmid DNA, such as base substitutions and base additions or deletions. Among them, Stratagene’s QuikChange site-directed mutagenesis kit is extremely useful and simple, and probably one of the most favored4. It requires a high-fidelity DNA polymerase that minimizes unwanted mutations, such as KOD hot start DNA polymerase, Pfu DNA polymerase, or Phusion® high-fidelity DNA polymerase, to amplify the whole plasmid with complementary primer pairs, carrying the desired mutation in the form of mismatches to the original plasmid. The parental DNA template is eliminated by treating with DpnI, which destroys the methylated template DNA5. The resulting nicked DNA is transformed into competent E. coli cells for nick repair.

Despite its widespread use, the QuikChange system has limitations. The fact that the primers are completely complementary, and hence favor self-annealing limits the PCR product yield and gives rise to false positives6. The complementary primer pairs favor “primer-dimer” formation by partial annealing of a primer with the second primer in the reaction, instead of primer annealing to the template with mismatches, which causes low PCR amplification efficiency, and may lead to the formation of tandem primer repeats in resulting PCR products and hence a reduction in fidelity7,8. The complementary primer design results in the mutated plasmid containing staggered nicks, and thus the newly synthesized DNA cannot be used as a template for subsequent amplification4. In addition, the originally developed QuikChange method requires the altered nucleotides to be introduced in the middle of both primers, limiting the introduction of multiple mutations4 as well as large changes9.

To circumvent these limitations, many modified versions of the QuikChange site-directed mutagenesis method have been developed4,1012. These methods use partially overlapping primers to reduce the formation of primer dimers and hence improve PCR amplification efficiency. Despite high efficiency, these approaches require primers containing the desired mutations in the template annealing regions, which limits the introduction of large changes required in some functional studies. Recently, several labs reported alternatives, such as overlap extension PCR (OE-PCR)1316 and homologous recombination-based methods1725, for creating mutations in vitro or in vivo. While OE-PCR provides efficient methods for introducing multiple and large changes, they involve multiple rounds of PCR and DNA purification, limiting the creation of multiple mutations simultaneously. Homologous recombination-based approaches rely on in vitro enzymatic treatment of DNA fragments for assembly. They always suffer from lower efficiency and fidelity when introducing mutations at more than five sites since the simultaneous assembly of more than five fragments is difficult, contributing to lower efficiency26 and non-specific recombination events24. Given these limitations, we aimed to develop more flexible protocols for making specific mutations.

Inspired by the concept of restriction-free cloning27 and recent advances in DNA sequence assembly28, we developed a new system for generating large and multiple changes in plasmid DNA. This system requires two rounds of PCR and subsequent annealing to generate mutated DNA fragments with compatible “sticky hands” at their 5′ ends for “hand-in-hand” assembly. Since the system requires two rounds of PCR followed by ligation of the sticky ends of the resulting DNA fragments, we named the method LFEAP mutagenesis (Ligation of Fragment Ends After PCR). Using this method, we can create a variety of DNA modifications, such as point mutations, substitutions, deletions, insertions, and multiple-site mutations in vectors in a cost-efficient manner with high efficiency and fidelity.

Results

Method overview

The mechanism of LFEAP mutagenesis for generating basic mutations, such as point mutations, substitutions, deletions, and insertions, is shown in Fig. 1. To generate basic mutations, LFEAP mutagenesis requires an “overhang” region and four primers. As shown in Fig. 1B and C, the overhang sequence can be a short sequence at the 5′ terminus of the region to be mutated (for point mutation, deletion, and insertion and substitution of short DNA sequences), or inside the region to be modified (for insertion and substitution of long DNA sequences). The primers designed for basic mutations are shown in Fig. 1B and C. Forward primer 1 (Fw1) and reverse primer 1 (Rv1) were designed to flank the overhang region. Fw1 contained mutations at its 5′ end that were incorporated into the first-round PCR products. Forward primer 2 (Fw2) and reverse primer 2 (Rv2) were designed to have additional overhang sequence at the 5′ ends that were incorporated into the second-round PCR products. All types of basic mutations proceeded similarly (Fig. 1A). (i) The first-round PCR was the exponential amplification of the target vector using Fw1 and Rv1. Fw1 contained mutations at its 5′ extension, and so the resulting PCR products contained mutations at the 5′ extension. The PCR products were gel purified to remove primers and templates. (ii) The second-round PCR used the DNA products generated in the first-round PCR as templates and Fw2 or Rv2 alone to generate single-stranded DNA fragments. The Fw2 and Rv2 contained overhangs at their 5′ extension. The resulting PCR products contained an overhang at the 5′ terminus. (iii) After treating with polynucleotide kinase (PNK) for 5′ phosphorylation, the two complementary single-stranded DNAs generated in the second-round PCR were then annealed to form double-stranded DNA with 5′ protruding ends. (iv) The double-stranded DNAs with sticky ends were joined using DNA ligase. (v) These ligated products were transformed into competent E. coli cells, and the presence of modifications was confirmed by DNA sequencing.

Figure 1.

Figure 1

Schematic representation of the LFEAP mutagenesis procedure for basic mutations. (A) The mutagenesis reaction requires five steps. Step 1: first-round PCR to introduce mutation using primers Fw1 and Rv1. Step 2: second-round PCR to introduce overhang using DNA fragments generated in the first-round PCR as templates and primer Fw2 or Rv2. Step 3: phosphorylation and annealing of two single-strand DNA fragments generated in the second-round PCR. Step 4: ligation of annealed fragments generated in step 3. Step 5: transformation of ligation products into competent E. coli cells. (B) An example showing primer design, overhang region, and region to be mutated. (C) The mechanism of LFEAP mutagenesis for generating a point mutation, deletion, insertion, and substitution. Fw: forward primer, Rv: reverse primer, OH: overhang region, Del: region to be deleted, Ins: DNA sequence to be inserted, Sub: region to be substituted.

The procedure for introducing mutations at multiple sites is shown in Fig. 2. The multiple-site mutagenesis can be considered as a combination of many basic mutations. Each site mutation requires an overhang region and four primers as for basic mutations (Fig. 2A). The procedure for introducing multiple changes with LFEAP mutagenesis required four steps. (i) In the first-round PCR, five PCRs in parallel were performed to generate five double-stranded DNA fragments using primer pairs Fw1-1 and Rv1-1, Fw2-1 and Rv2-1, Fw3-1 and Rv3-1, Fw4-1 and Rv4-1, and Fw5-1 and Rv5-1. The resulting PCR products contained the desired mutations at their 5′ extension. (ii) In the second-round PCR, two single primer PCRs in parallel were performed to generate two complementary single-stranded DNA fragments using each fragment generated in the first-round PCR as the template and single primers of Fw1-2 or Rv1-2, Fw2-2 or Rv2-1, Fw3-2 or Rv3-2, Fw4-2 or Rv4-2, and Fw5-1 or Rv5-1. (iii) After treating with PNK, the complementary single-stranded DNA products were then annealed to form double-stranded DNAs with sticky ends. (iv) The annealed multi-part DNAs with sticky ends were sealed by DNA ligase to form a transformable plasmid.

Figure 2.

Figure 2

Schematic details of the generation of multiple mutations with LFEAP mutagenesis. (A) Primer design. For each modification, a 6–10 nucleotide region that is adjacent to the 5′ end of the mutation region is assigned as an overhang region. The mutagenesis reaction requires four steps: (B) first-round PCR to introduce mutations using primer pairs; (C) second-round PCRs to incorporate overhangs at the 5′ ends of resulting DNA products using DNA products generated in the first-round PCR as templates and single primers; (D) phosphorylation and annealing of two complementary single-stranded DNA fragments generated in the second-round PCR; and (E) ligation of the annealed multi-part DNAs with sticky ends and transformation into competent E. coli cells. Fw: forward primer, Rv: reverse primer, OH 1–5: overhang regions.

Optimal overhang adapter sequence

To identify the optimal overhang sequence required for LFEAP mutagenesis, we followed the procedure as shown in Fig. 1A to add two nucleotides (TA) in the middle of the XhoI restriction site (CTCGAG) in pcDNA™3.1 (+)-MCM6 plasmid, thereby disrupting the restriction site29 using a series of primers with 5′ overhangs ranging from 0 to 20 nucleotides (see Fig. 3A for primer design). We evaluated the performance of LFEAP mutagenesis by determining the efficiency (colony forming units (CFUs) per microgram of ligated DNA after transformation) and the fidelity (percentage of clones containing the desired mutations). The mutations were carried out by LFEAP mutagenesis, and the resulting plasmids were extracted from the transformed E. coli. An overhang sequence of 0 to 3 nucleotides in length in the resulting PCR products was insufficient for efficient mutagenesis (Fig. 3B). Overhangs of four or more nucleotides resulted in the efficiency and fidelity of mutagenesis reactions increasing sharply up to 10 nucleotides, with a maximum efficiency of approximately 8,000 CFUs and fidelity of 100%. Interestingly, no further improvement in efficiency and fidelity was observed when continually increasing the length of the overhang sequence. On the contrary, the efficiency and fidelity suffered a slight decrease when longer overhang sequences were used (Fig. 3B). We conclude that an overhang of 6–10 nucleotides is optimal for LFEAP mutagenesis.

Figure 3.

Figure 3

Effect of overhang size on LFEAP mutagenesis efficiency. (A) Schematic details show the primer design for determining optimal overhang size. The mutations are highlighted with red letters. (B) The overhang size is plotted against the achieved efficiencies and fidelities. Reported results are the mean ± s.d. of three independent experiments. Overhangs of 6–10 nucleotides give the maximum efficiency and fidelity, while a decrease in efficiency and fidelity is observed when longer overhangs are used.

Basic mutations

To investigate the capability of LFEAP mutagenesis for basic mutations, we provided examples from our work using genes (yaaU, ileS, talB and apaG cloned from the E. coli genome and GAST, MCM6, PRRT2, and SLC18A2 cloned from a human cDNA library) cloned into pNGFP-BC or pCGFP-EU vector, and ran LFEAP mutagenesis to produce mutations at desired sites (Fig. 1C; see Supplementary Methods for detailed experimental procedures). The primers used for creating mutations were designed following the rules shown in Fig. 1B and are listed in Supplementary Table S1. The DNA products resulting from LFEAP mutagenesis were evaluated by 1% agarose gel electrophoresis, and the presence of desired mutations was verified via DNA sequencing (see Supplementary Figure S1 for point mutations, Supplementary Figure S2 for substitutions, Supplementary Figure S3 for deletions, and Supplementary Figure S4 for insertions).

  1. Point mutations. As examples, we performed seven point mutations within plasmid coding sequences: yaaU (R205A), ileS (K581A), talB (K193C), apaG (R26A), GAST (K75A), MCM6 (Q641A), and SLC18A2 (K354A). Under our test conditions, 8,000–9,000 CFUs and an average fidelity of 98.5% were achieved with LFEAP mutagenesis (Table 1). By contrast, commercial QuikChange mutagenesis yielded fewer CFUs (7,000–8,000) and a lower average fidelity of 86.2% (Supplementary Table S5).

  2. Substitutions. As examples, we performed i) substitution of six nucleotides in yaaU and nine nucleotides in GAST, and ii) substitution of 30 nucleotides in yaaU and 36 nucleotides in GAST. Accordingly, thousands of colonies and nearly 100% fidelity were obtained (Table 2).

  3. Deletions. As examples, we performed (i) deletion of single nucleotides, i.e., yaaU 909 A, ileS 2096 T, talB 552 C, apaG 253 G, GAST 183 A, MCM6 1745T, PPRT2 741 C, and SLC18A2 1415 G, ii) deletion of 12 nucleotides in selected genes resulting in yaaU (Del F28–G31), ileS (Del R202–R205), talB (Del Q28–D31), apaG (Del G63–G66), GAST (Del H55–R58), MCM6 (Del D202–K205), PPRT2 (Del D43–E45), and SLC18A2 (Del D73–Q76) mutants, and iii) deletion of longer nucleotide sequences, i.e., 1,272 nucleotides from yaaU, 2,748 nucleotides from ileS, 885 nucleotides from talB, 309 nucleotides from apaG, 238 nucleotides from GAST, 2,397 nucleotides from MCM6, 954 nucleotides from PPRT2, and 1,476 nucleotides from SLC18A2. We obtained high efficiency and fidelity as verified by DNA sequencing (Table 3).

  4. Insertions. As examples, we performed i) insertion of a single nucleotide into target genes yielding yaaU (909 A), ileS (2096 T), talB (552 C), apaG (253 G), GAST (183 A), MCM6 (1745 T), PPRT2 (741 C), and SLC18A2 (1415 G) mutants, ii) insertion of 12 nucleotides into target genes, producing yaaU (Ins F28-AAAA), ileS (Ins E201-AAAA), talB (Ins Q28-AAAA), apaG (Ins Q63-AAAA), GAST (Ins H55-AAAA), MCM6 (Ins D202-AAAA), PPRT2 (Ins D43-AAAA), and SLC18A2 (Ins D73-AAAA) mutants, and iii) insertion of 60 nucleotides into yaaU and SLC18A2 yielding mutants of yaaU (Ins F28-VEESPKVPGEGPGHSEAETG) and SLC18A2 (Ins D73-VEESPKVPGEGPGHSEAETG). Large colony numbers and high fidelity were achieved (Table 4).

Table 1.

The efficiency and fidelity of creating point mutations with LFEAP mutagenesis.

Gene Gene ID Size (bp) Vector Mutation CFUs/µg DNAa Positive (%)b
yaaU 944766 1,332 pNGFP-BC R205A 9672 ± 593 96.7 ± 5.8
ileS 944761 2,817 pCGFP-BC K581A 8254 ± 782 90.0 ± 10.0
talB 944748 954 pNGFP-BC K193C 8833 ± 714 93.3 ± 11.5
apaG 944772 378 pCGFP-BC R26A 9755 ± 868 96.7 ± 5.8
GAST 2520 306 pNGFP-EU K75A 8636 ± 874 90.0 ± 10.0
MCM6 4175 2,466 pNGFP-EU Q641A 8571 ± 883 96.7 ± 5.8
SLC18A2 6571 1,545 pCGFP-EU K354A 8931 ± 993 100.0 ± 0.0

aReported results are the mean ± s.d. of three independent experiments.

bFor each independent experiment, ten of colonies were checked by DNA sequencing.

Table 2.

The efficiency and fidelity of creating substitutions with LFEAP mutagenesis.

Gene Gene ID Size (bp) Vector Mutation CFU/µg DNAa Positive (%)b
yaaU 944766 1,332 pNGFP-BC DE224AA 7375 ± 18 100 ± 0
GAST 2520 306 pNGFP-EU SQQ27AAA 7296 ± 16 96.7 ± 5.8
yaaU 944766 1,332 pNGFP-BC RKGRVKECEE202AAAAAAAAAA 8178 ± 21 100 ± 0
GAST 2520 306 pNGFP-EU EQQGPASHHRRQ48AAAAAAAAAAAA 7827 ± 15 100 ± 0

aReported results are the mean ± s.d. of three independent experiments.

bFor each independent experiment, ten of colonies were checked by DNA sequencing.

Table 3.

The efficiency and fidelity of creating deletions with LFEAP mutagenesis.

Gene Gene ID Size (bp) Vector Mutations CFU/µg DNAa Positive (%)b
yaaU 944766 1,332 pNGFP-BC Del 909 A 8089 ± 824 100 ± 0
ileS 944761 2,817 pCGFP-BC Del 2096 T 7132 ± 717 100 ± 0
talB 944748 954 pNGFP-BC Del 552 C 8259 ± 725 96.7 ± 5.8
apaG 944772 378 pCGFP-BC Del 253 G 7433 ± 813 90 ± 10
GAST 2520 306 pNGFP-EU Del 183 A 8319 ± 712 100 ± 0
MCM6 4175 2,466 pCGFP-EU Del 1745T 6559 ± 749 96.7 ± 5.8
PPRT2 112476 1,023 pNGFP-EU Del 741 C 7539 ± 721 100 ± 0
SLC18A2 6571 1,545 pCGFP-EU Del 1415 G 7975 ± 816 100 ± 0
yaaU 944766 1,332 pNGFP-BC Del F28-G31 6938 ± 717 90 ± 10
ileS 944761 2,817 pCGFP-BC Del R202-R205 6712 ± 711 90 ± 10
talB 944748 954 pNGFP-BC Del Q28-D31 9976 ± 810 96.7 ± 5.8
apaG 944772 378 pCGFP-BC Del Q63-G66 9655 ± 819 100 ± 0
GAST 2520 306 pNGFP-EU Del H55-R58 8575 ± 821 96.7 ± 5.8
MCM6 4175 2,466 pCGFP-EU Del D202-K205 5956 ± 712 100 ± 0
PPRT2 112476 1,023 pNGFP-EU Del D43-E45 7742 ± 611 100 ± 0
SLC18A2 6571 1,545 pCGFP-EU Del D73-Q76 6938 ± 713 90 ± 10
yaaU 944766 1,332 pNGFP-BC Del K11-N434 8675 ± 14 96.7 ± 5.8
ileS 944761 2,817 pCGFP-BC Del G14-A929 7426 ± 622 90 ± 10
talB 944748 954 pNGFP-BC Del V14-K308 7494 ± 819 100 ± 0
apaG 944772 378 pCGFP-BC Del V14-F116 6335 ± 723 100 ± 0
GAST 2520 306 pNGFP-EU Del G14-L92 9162 ± 810 96.7 ± 5.8
MCM6 4175 2,466 pCGFP-EU Del Q14-V812 8494 ± 717 100 ± 0
PPRT2 112476 1,023 pNGFP-EU Del V14-S331 7796 ± 725 90 ± 10
SLC18A2 6571 1,545 pCGFP-EU Del E14-I505 8176 ± 821 97.6 ± 5.8

aReported results are the mean ± s.d. of three independent experiments.

bFor each independent experiment, ten of colonies were checked by DNA sequencing.

Table 4.

The efficiency and fidelity of creating insertions with LFEAP mutagenesis.

Gene Gene ID Size (bp) Vector Mutation CFU/µg DNAa Positive (%)b
yaaU 944766 1,332 pNGFP-BC Ins 909 A 8671 ± 56 100 ± 0
ileS 944761 2,817 pCGFP-BC Ins 2096 T 7453 ± 12 100 ± 0
talB 944748 954 pNGFP-BC Ins 552 C 8246 ± 22 96.7 ± 5.7
apaG 944772 378 pCGFP-BC Ins 253 G 7983 ± 21 100 ± 0
GAST 2520 306 pNGFP-EU Ins 183 A 7864 ± 33 100 ± 0
MCM6 4175 2,466 pCGFP-EU Ins 1745T 7519 ± 19 100 ± 0
PPRT2 112476 1,023 pNGFP-EU Ins 741 C 7884 ± 32 90 ± 10
SLC18A2 6571 1,545 pCGFP-EU Ins 1415 G 8696 ± 12 100 ± 0
yaaU 944766 1,332 pNGFP-BC Ins F28-AAAA 9515 ± 24 100 ± 0
ileS 944761 2,817 pCGFP-BC Ins E201-AAAA 8473 ± 16 100 ± 0
talB 944748 954 pNGFP-BC Ins Q28-AAAA 8297 ± 25 96.7 ± 5.7
apaG 944772 378 pCGFP-BC Ins Q63-AAAA 8157 ± 33 96.7 ± 5.7
GAST 2520 306 pNGFP-EU Ins H55-AAAA 7819 ± 18 100 ± 0
MCM6 4175 2,466 pCGFP-EU Ins D202-AAAA 6468 ± 21 100 ± 0
PPRT2 112476 1,023 pNGFP-EU Ins D43-AAAA 8411 ± 19 96.7 ± 5.7
SLC18A2 6571 1,545 pCGFP-EU Ins D73-AAAA 7612 ± 26 100 ± 0
yaaU 944766 1,332 pNGFP-BC Ins F28-VEESPKVPGEGPGHSEAETG 8536 ± 32 90 ± 10
SLC18A2 6571 1,545 pCGFP-EU Ins D73- VEESPKVPGEGPGHSEAETG 9445 ± 27 96.7 ± 5.7

aReported results are the mean ± s.d. of three independent experiments.

bFor each independent experiment, ten of colonies were checked by DNA sequencing.

Multiple-site mutations

The experiments described above demonstrated that LFEAP mutagenesis is an efficient and precise method for introducing single as well as large changes in plasmids. To test the feasibility of LFEAP mutagenesis for simultaneous introduction of multiple mutations in plasmid, we performed experiments to generate 3 (E52A, R309A, and Q668A), six (E52A, D160A, D253A, D362A, E461A, and D564A), 10 (E52A, D160A, R207A, R309A, D362A, R416A, D511A, D564A, Q668A, and D784A), and 15 (E52A, E103A, D160A, R207A, D253A, R309A, D362A, R416A, E461A, D511A, D564A, R619A, Q668A, E719A, and D784A) point mutations in the MCM6 gene in the pNGFP-EU-MCM6 plasmid (see Fig. 2 for a schematic detailing the procedure).

Multiple-site mutagenesis was performed by following the procedure as shown in Fig. 2. Accordingly, all mutations of interest were introduced into the 5′ ends of fragments in the first-round PCR step. After gel purification, these fragments were used as templates for second-round PCR to add overhang adapter sequences onto the 5′ ends, followed by annealing and ligating to form plasmids with the desired mutations. The presence of mutations was verified by DNA sequencing. Figure 4 shows the efficiency and fidelity of the generation of multiple-site modifications with LFEAP mutagenesis. As we expected, the efficiency of mutagenesis decreased with increasing number of mutations. The CFU per of DNA dipped to around 250 when simultaneously creating 15 mutations (Fig. 4). By contrast, the fidelity dropped slightly but remained above 60% even for 15 mutations. Overall, the method performs well in multiple-site mutagenesis.

Figure 4.

Figure 4

Mutations at multiple sites with LFEAP mutagenesis. The number of mutations is plotted against the achieved efficiencies and fidelities. Results are the mean ± s.d. of three independent experiments.

Mutations in large plasmids

As almost DNA polymerases cannot amplify long templates with high efficiency and fidelity, LFEAP mutagenesis uses a new strategy in which the large DNA is split into small pieces. The procedure for introducing mutations into large plasmids (Fig. 5A) was similar to that for introducing multiple-site mutations (Fig. 2). The first-round PCR cut the large plasmid into small pieces (~5 kb each) with mutagenic ends, followed by the second-round PCR and the subsequent annealing that yielded DNA fragments with compatible ends. These were simultaneously joined to each other using T4 DNA ligase, yielding the mutagenized plasmid.

Figure 5.

Figure 5

Mutations in larger plasmids. (A) Schematic representation of LFEAP mutagenesis in large plasmids. The first-round PCRs cut large plasmids into small pieces (~5 kb) with mutagenic ends. The second-round PCRs and the subsequent annealing yield multi-part DNAs with sticky ends, which can be seamlessly joined by T4 DNA ligase simultaneously. (B) Introduction of mutations in a 25 kb plasmid. Electrophoresis on a 1% agarose gel shows the DNA products generated by the procedure described in the Supplementary Methods. Lanes 1–5: DNA fragments 1 to 5 generated by first-round PCRs. Lane 6: mixture of annealed multi-part DNAs with sticky ends generated by second-round PCRs and the subsequent annealing. Lane 7: the mixture as shown in lane 6 treated with T4 DNA ligase. Lane 8: 1 kb DNA ladder. (C) Introduction of mutations in a 50 kb plasmid. Electrophoresis on a 1% agarose gel shows the DNA products generated by the procedure shown in the Supplementary Methods. Lanes 1–10: DNA fragments 1 to 10 generated by first-round PCRs. Lane 11: mixture of annealed multi-part DNAs with sticky ends generated by second-round PCRs and the subsequent annealing. Lane 12: the mixture as shown in lane 11 treated with T4 DNA ligase. Lane 13: 1 kb DNA ladder. (D) Electrophoresis on a 0.5% agarose gel of a 25 kb plasmid. Lane 1: 25 kb plasmid before introducing mutations. Lanes 2–6: 25 kb plasmids after introducing mutations propagated from five single colonies. Lane 7: GeneRuler high range DNA ladder (Thermo Fisher Scientific). Incorrect patterns are marked with a ‘×’. (E) Electrophoresis on a 0.5% agarose gel of a 50 kb plasmid. Lane 1: GeneRuler high range DNA ladder (Thermo Fisher Scientific). Lane 2: 50 kb plasmid before introducing mutations. Lanes 2–7: 50 kb plasmids after introducing mutations propagated from five single colonies. Incorrect patterns are marked with a ‘×’. The full-length agarose gels of 25 kb and 50 kb plasmids are presented in Supplementary Figure S11.

As examples, we first performed experiments to create five point mutations in a 25 kb plasmid (see Supplementary Figure S5 for the plasmid structure and the primer design, and Supplementary Information for the plasmid sequence) with such an approach (see Supplementary Methods for the detailed experimental procedure). Accordingly, this 25 kb plasmid was cut into five small fragments (6, 4, 5, 6, and 4 kb) in the first-round PCRs (Fig. 5B, lanes 1, 2, 3, 4, and 5). After treating with PNK, the DNA products generated by the second-round PCR and the subsequent annealing were mixed at a 1:1:1:1:1 molar ratio of fragments 1 to 5 (Fig. 5B, lane 6), followed by ligation to seal nicks between each fragment, causing the DNA band to shift upwards to a higher molecular weight on the agarose gel (Fig. 5B, lane 7). After transforming chemically competent E. coli host cells with these ligated DNAs, 1,848 ± 165 CFUs (n = 3) per µg of DNA were obtained. To evaluate the fidelity of LFEAP mutagenesis for a 25 kb plasmid, we randomly chose 20 colonies from each transformation and isolated using the QIAGEN® Large-Construct Kit. We then performed DNA electrophoresis of these 25 kb plasmids before and after introducing mutations by LFEAP to separate those damaged during the cloning procedure. The plasmids were propagated from single colonies. About 60% of newly constructed plasmids were damaged (Fig. 5D, six isolated plasmids are shown). The positive plasmids shown on the agarose gel were chosen and further confirmed by DNA sequencing of full DNA plasmid or each joining site (Supplementary Figure S6 and Supplementary Figure S7). Few unwanted mutations were found in the plasmids after introducing mutations by LFEAP mutagenesis (~70% fidelity), and most unwanted mutations were found within the joining sites.

Furthermore, we performed experiments to create a point mutation in a 50 kb plasmid (see Supplementary Figure S8 for the plasmid structure and the primer design, Supplementary Information for the plasmid sequence, and Supplementary Methods for the detailed experimental procedure). Accordingly, this 50 kb plasmid was cut into 10 DNA fragments (6, 6, 4, 5, 5.5, 6, 6, 5, 5, and 6) in the first-round PCR (Fig. 5C, lane 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10, respectively). The second-round PCR and the subsequent annealing yielded DNA products with overhang sequences that were joined up by T4 DNA ligase (Fig. 5C, lane 12). After transformation, 526 ± 58 CFUs (n = 3) per µg of DNA were obtained. We randomly chose 20 colonies from each transformation, and the plasmids propagated from single colonies were isolated and then subjected to agarose gel electrophoresis (Fig. 5E, six isolated plasmids are shown). The positive plasmids shown on the agarose gel were chosen and further confirmed by DNA sequencing of the full DNA plasmid or each joining site (Supplementary Figure S9 and Supplementary Figure S10). Similar to the 25 kb plasmids, few unwanted mutations were found in the plasmids after introducing mutations by LFEAP mutagenesis (~50%) and most unwanted mutations were found within the joining sites.

In summary, LFEAP mutagenesis is efficient in introducing mutations into large plasmids of up to 50 kb in our test conditions.

Discussion

Our newly developed method provides several advantages over existing technologies for DNA mutagenesis. LFEAP mutagenesis is based on a two-round PCR procedure, followed by ligation of the resulting DNA fragments. The primers for LFEAP mutagenesis are designed such that all modified nucleotides and overhang regions are introduced at the 5′ end of the template annealing regions, which greatly reduces the complementary region of the primers and allows full displacement of the modified nucleotides outside the template annealing region. These strategies lead to several advantages of LFEAP mutagenesis. (1) The primer design strategy eliminates primer-dimer formation and mispriming, which ensures exponential amplification for high PCR efficiency and facilitates the introduction of long mutation sequences. (2) LFEAP mutagenesis uses linear PCR to generate overhang cohesive ends for direct ligation; hence only the most common lab enzymes like high-fidelity DNA polymerase, T4 DNA ligase, and PNK are required. No more special enzymes, plasmids, kits, or host strains are required. (3) Our two-round PCR design dilutes parental templates, which reduces the background and improves the efficiency of mutagenesis. (4) LFEAP mutagenesis efficiently assembles the modified DNA fragments in vitro by a traditional ligation reaction that can be accurately manipulated and monitored by agarose gel electrophoresis directly.

Furthermore, LFEAP mutagenesis provides a versatile method for handling different types of mutagenesis, such as point mutations, insertions, deletions, substitutions, and multiple-site changes. While most widely used PCR-based mutagenesis methods, such as QuikChange site-directed mutagenesis and its variations, are effective for producing single or a few nucleotide changes in a small plasmid, larger or multiple-site changes are more difficult4,912,30. LFEAP mutagenesis overcomes this limitation and can incorporate large nucleotides changes since the modified nucleotides are introduced at the 5′ end of the template annealing regions rather than in the middle of longer mutagenic primers. While many strategies, based on either homologous recombination24,31 or OE4,15,16, have been reported and developed for multiple-site mutations, their efficiency and fidelity drop precipitously when more than five sites are targeted simultaneously. LFEAP mutagenesis can simultaneously create up to 15 mutations with higher efficiency since the assembly of each fragment with desired mutations is guided by overhang adapter sequences, which greatly improves assembly efficiency, and hence mutagenesis efficiency.

LFEAP mutagenesis also offers an efficient method to introduce mutations into large plasmid. Introduction of mutations in larger plasmids is a slow and labor-intensive process, especially for multiple mutations9. Low efficiency is one of the limitations for long-range PCR due to the high error rate. Most commercially available DNA polymerases can only amplify DNA up to 20 kb with high fidelity. To overcome this limitation, LFEAP mutagenesis splits large plasmids into small pieces that are within the range of recommended values for most high-fidelity polymerases for maintaining the accurate DNA sequence during amplification. The mutations are added to the 5′ ends of the resulting DNA fragments, which are then joined up with overhang adapter sequences yielding plasmid with the desired mutations. Our experiments show that this strategy has high efficiency and fidelity for creating changes in large plasmids.

One of the limiting factors in LFEAP mutagenesis is the PCR itself. LFEAP mutagenesis requires amplification of the entire plasmid, which may introduce unwanted mutations by off-target polymerase errors, especially when working with large plasmids. In our experience, plasmid truncations are sometimes found in large plasmids (Fig. 5D and E). This is common in plasmids over 10 kb and inevitable because larger plasmids are likely to be damaged during purification and handling32. LFEAP mutagenesis requires large plasmids to be divided into small DNA fragments of 4–6 kb. Most commercially available high-fidelity DNA polymerases can perform PCR in this range with ultra-low error rates (e.g., 4.4 × 10−7 for Phusion® High-Fidelity DNA Polymerase as reported by Finnzymes/Thermo Scientific). For our method, most of the DNA operations are concentrated in joining site zones. These characteristics of LFEAP mutagenesis may explain why lower unwanted mutation rates were found in the plasmids after introducing mutations by LFEAP mutagenesis and most unwanted mutations were found in the joining sites. Hence, our method is sufficient for most routine mutagenesis. The other disadvantage associated with LFEAP mutagenesis is that it needs two rounds of PCR. Luckily, primer synthesis is no longer costly, and the extra time required for a second PCR reaction is compensated for since there is no need for treatment with restriction enzymes, with is time consuming. Due to high stability and efficiency, we always obtained the desired mutants in one attempt, there by saving time and labor.

In short, we developed a simple, robust, and reliable method for creating a variety of mutations. Figure 6 summarizes the detailed protocol for the generation of single-site mutations with LFEAP mutagenesis. Multiple-site plasmid mutagenesis, as well as mutagenesis in large plasmids, can be achieved easily with high efficiency and fidelity by following the appropriate modifications of this protocol.

Figure 6.

Figure 6

Schematic of the LFEAP mutagenesis protocol for generating single-site mutation in plasmid DNA. A detailed overview of the primer design, mutagenesis procedure, and experimental conditions is shown.

Materials and Methods

E. coli strains, primers, plasmids, and reagents

Host strain E. coli DH5α was obtained from Invitrogen Corporation (Carlsbad, CA, USA). The competent DH5α cells were prepared using the calcium chloride method33. Bacteria containing plasmids were cultured in lysogeny broth (LB) medium34 with appropriate antibiotics (kanamycin or ampicillin at 50 or 100 μg/ml, respectively). All the primers used were commercially synthesized by Invitrogen Corporation (Carlsbad, CA, USA). The vectors, pET22b and pcDNA™ 3.1 (+) were obtained from Invitrogen Corporation (Carlsbad, CA, USA). The vectors, pNGFP-BC, pCGFP-BC, pNGFP-EU, and pCGFP-EU were courtesy of Dr. Eric Gouaux. Phusion® high-fidelity DNA polymerase, DNA marker, Taq DNA polymerase, T4-PNK, and T4 DNA ligase were purchased from New England Biolabs (Ipswich, MA, USA). Human cDNA library was purchased from Clontech Laboratories (Mountain View, CA, USA). QIAquick PCR purification kit, QIAquick gel extraction kit, QIAprep spin miniprep kit, and Large-Construct Kit were purchased from Qiagen (Hilden, Germany).

PCR and ligation

The primer sequences used in this study were listed in Supplementary Table S1. Unless otherwise stated, 50 μl PCR reactions were performed using Phusion® high-fidelity DNA polymerase (New England Biolabs). The PCR conditions are listed in Supplementary Table S2 and Supplementary Table S3. The resulting PCR products in the first round were separated via 1% agarose gel electrophoresis. The complementary DNA products from second-round PCRs were annealed without purification (see Supplementary Table S4 for annealing conditions). DNA ligation reactions were performed to join up DNA fragments with complementary sticky ends in a final volume of 20 μl using T4 DNA ligase following the standard protocol from New England Biolabs. In brief, the longer and shorter DNA fragments were mixed at a molar ratio of 1:3–1:10. The reaction was incubated at room temperature for 2 h. After heat inactivation at 65 °C for 10 min, the reaction was chilled on ice.

Plasmid transformation, isolation, and sequencing

Transformation of the ligated DNA products into E. coli was carried out using the heat shock method. In brief, 10 μl of the ligation products and 100 μl of competent DH5α cells were mixed and incubated for 15 min on ice, and subsequently heat shocked at 42 °C for 1 min and then placed back on ice. LB media (500 μl) was added, and the transformed cells were incubated at 37 °C for 60 min with agitation. After incubation, cells were pelleted and resuspended in 100 µl flash LB, which was then spread on LB agar plates containing ampicillin (100 μg/ml) or kanamycin (50 μg/ml). The plates were incubated overnight at 37 °C. The resulting colonies were then counted to determine the efficiency of mutagenesis reactions. Ten to twenty colonies were randomly selected from each transformation, and the plasmids were isolated using the QIAprep Spin Miniprep Kit or Large-Construct Kit. DNA sequencing was performed to assess the fidelity of the mutagenesis reaction.

Determining optimal overhang size needed for the LFEAP mutagenesis method

Primers were designed for the addition of two nucleotides (TA) in the middle of the XhoI restriction site (CTCGAG) in pcDNA3.1 (+)-MCM6 plasmid (Fig. 3A), thereby disrupting the restriction site29. The overhang size was varied from 0 to 20 bp (see Supplementary Table S1 for primer sequences). The mutations were carried out by LFEAP mutagenesis (Fig. 1A). The efficiency of mutagenesis reaction as the function of overhang size was determined by counting the resulting bacterial colonies from each transformation. Ten colonies were randomly selected from each transformation, and the plasmids were isolated using the QIAprep Spin Miniprep Kit. The fidelity of mutagenesis reaction as the function of overhang size was measured by sequencing the mutated sites.

Statistical analysis

Data points represent the mean from three independent experiments, and, where indicated, error bars represent one standard deviation from the mean.

Electronic supplementary material

Supplementary DATA (6.2MB, pdf)
Supplementary Dataset 1 (117.2KB, zip)
Supplementary Dataset 2 (244.1KB, zip)

Acknowledgements

We thank Dr. Ranjan Kumar Singh (Vrije Universiteit Brussels, Belgium) for the meaningful discussion. We thank Dr. Eric Gouaux (Oregon Health & Science University, USA) for kindly providing the pNGFP-BC, pCGFP-BC, pNGFP-EU, and pCGFP-EU vectors. This work was supported by National Modern Agriculture Industry Technique Systems (CARS-02) to Jingao Dong and Starting Grant from Hebei Agricultural University to Fanli Zeng (grant number ZD201622).

Author Contributions

F.Z., J.D., and Y.L. designed the experiments and drafted the manuscript. F.Z., S.Z., Z.H., S.D., Y.M. and P.L. carried out the practical work, S.Z., Z.H. were involved in the research discussions and helped to finalize the manuscript. All authors read and approved the final manuscript.

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-20169-8.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Jingao Dong, Email: shmdjg@hebau.edu.cn.

Yibin Lin, Email: Yibin.lin@uth.tmc.edu.

References

  • 1.Yang W, Jiang LH. Site-directed mutagenesis to study the structure-function relationships of ion channels. Methods Mol Biol. 2013;998:257–266. doi: 10.1007/978-1-62703-351-0_20. [DOI] [PubMed] [Google Scholar]
  • 2.Rushworth CA, Guy JL, Turner AJ. Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS J. 2008;275:6033–6042. doi: 10.1111/j.1742-4658.2008.06733.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hsieh PC, Vaisvila R. Protein engineering: single or multiple site-directed mutagenesis. Methods Mol Biol. 2013;978:173–186. doi: 10.1007/978-1-62703-293-3_13. [DOI] [PubMed] [Google Scholar]
  • 4.Liu H, Naismith JH. An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 2008;8:91. doi: 10.1186/1472-6750-8-91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pingoud A, Jeltsch A. Structure and function of type II restriction endonucleases. Nucleic Acids Res. 2001;29:3705–3727. doi: 10.1093/nar/29.18.3705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lorenz, T. C. Polymerase chain reaction: basic protocol plus troubleshooting and optimization strategies. J Vis Exp e3998, 10.3791/3998 (2012). [DOI] [PMC free article] [PubMed]
  • 7.Edelheit O, Hanukoglu A, Hanukoglu I. Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies. BMC Biotechnol. 2009;9:61. doi: 10.1186/1472-6750-9-61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xia Y, Chu W, Qi Q, Xun L. New insights into the QuikChange process guide the use of Phusion DNA polymerase for site-directed mutagenesis. Nucleic Acids Res. 2015;43:e12. doi: 10.1093/nar/gku1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hallak LK, et al. Efficient method for site-directed mutagenesis in large plasmids without subcloning. PLoS One. 2017;12:e0177788. doi: 10.1371/journal.pone.0177788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zheng L, Baumann U, Reymond JL. An efficient one-step site-directed and site- saturation mutagenesis protocol. Nucleic Acids Res. 2004;32:e115. doi: 10.1093/nar/gnh110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Qi D, Scholthof KB. A one-step PCR-based method for rapid and efficient site-directed fragment deletion, insertion, and substitution mutagenesis. J Virol Methods. 2008;149:85–90. doi: 10.1016/j.jviromet.2008.01.002. [DOI] [PubMed] [Google Scholar]
  • 12.Li J, et al. Site-directed mutagenesis by combination of homologous recombination and DpnI digestion of the plasmid template in Escherichia coli. Anal Biochem. 2008;373:389–391. doi: 10.1016/j.ab.2007.10.034. [DOI] [PubMed] [Google Scholar]
  • 13.Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77:51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  • 14.An Y, et al. A rapid and efficient method for multiple-site mutagenesis with a modified overlap extension PCR. Appl Microbiol Biotechnol. 2005;68:774–778. doi: 10.1007/s00253-005-1948-8. [DOI] [PubMed] [Google Scholar]
  • 15.Zeng F, Zheng Y, Zheng Z, Malik AA, Lin Y. Multiple-site fragment deletion, insertion and substitution mutagenesis by modified overlap extension PCR. Biotechnology & Biotechnological Equipment. 2017;31:9. doi: 10.1080/13102818.2017.1279033. [DOI] [Google Scholar]
  • 16.Mitchell LA, et al. Multichange isothermal mutagenesis: a new strategy for multiple site-directed mutations in plasmid DNA. ACS Synth Biol. 2013;2:473–477. doi: 10.1021/sb300131w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bubeck P, Winkler M, Bautsch W. Rapid cloning by homologous recombination in vivo. Nucleic Acids Res. 1993;21:3601–3602. doi: 10.1093/nar/21.15.3601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang Y, Muyrers JP, Testa G, Stewart AF. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol. 2000;18:1314–1317. doi: 10.1038/82449. [DOI] [PubMed] [Google Scholar]
  • 19.Muyrers JP, Zhang Y, Stewart AF. Techniques: Recombinogenic engineering–new options for cloning and manipulating DNA. Trends Biochem Sci. 2001;26:325–331. doi: 10.1016/S0968-0004(00)01757-6. [DOI] [PubMed] [Google Scholar]
  • 20.Li MZ, Elledge SJ. Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods. 2007;4:251–256. doi: 10.1038/nmeth1010. [DOI] [PubMed] [Google Scholar]
  • 21.Sharan SK, Thomason LC, Kuznetsov SG, Court DL. Recombineering: a homologous recombination-based method of genetic engineering. Nat Protoc. 2009;4:206–223. doi: 10.1038/nprot.2008.227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang Y, Werling U, Edelmann W. SLiCE: a novel bacterial cell extract-based DNA cloning method. Nucleic Acids Res. 2012;40:e55. doi: 10.1093/nar/gkr1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.van Leeuwen, J., Andrews, B., Boone, C. & Tan, G. Rapid and efficient plasmid construction by homologous recombination in yeast. Cold Spring Harb Protoc 2015, pdbprot085100, 10.1101/pdb.prot085100 (2015). [DOI] [PubMed]
  • 24.Garcia-Nafria J, Watson JF, Greger IH. IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo assembly. Sci Rep. 2016;6:27459. doi: 10.1038/srep27459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Trehan A, et al. REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering. Sci Rep. 2016;6:19121. doi: 10.1038/srep19121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kostylev M, Otwell AE, Richardson RE, Suzuki Y. Cloning should be simple: Escherichia coli DH5alpha-mediated assembly of multiple DNA fragments with short end homologies. PLoS One. 2015;10:e0137466. doi: 10.1371/journal.pone.0137466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zeng F, et al. A restriction-free method for gene reconstitution using two single-primer PCRs in parallel to generate compatible cohesive ends. BMC Biotechnol. 2017;17:32. doi: 10.1186/s12896-017-0346-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zeng F, et al. AFEAP cloning: a precise and efficient method for large DNA sequence assembly. BMC Biotechnol. 2017;17:81. doi: 10.1186/s12896-017-0394-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Theriault G, et al. Nucleotide sequence of the PaeR7 restriction/modification system and partial characterization of its protein products. Nucleic Acids Res. 1985;13:8441–8461. doi: 10.1093/nar/13.23.8441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wu D, et al. A rapid and efficient one-step site-directed deletion, insertion, and substitution mutagenesis protocol. Anal Biochem. 2013;434:254–258. doi: 10.1016/j.ab.2012.11.028. [DOI] [PubMed] [Google Scholar]
  • 31.Liang X, Peng L, Li K, Peterson T, Katzen F. A method for multi-site-directed mutagenesis based on homologous recombination. Anal Biochem. 2012;427:99–101. doi: 10.1016/j.ab.2012.05.002. [DOI] [PubMed] [Google Scholar]
  • 32.Fitzgerald-Hayes, M. & Reichsman, F. DNA and biotechnology. 3rd edn, (Academic Press/Elsevier, 2010).
  • 33.Dagert M, Ehrlich SD. Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene. 1979;6:23–28. doi: 10.1016/0378-1119(79)90082-9. [DOI] [PubMed] [Google Scholar]
  • 34.Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic. Escherichia coli. J Bacteriol. 1951;62:293–300. doi: 10.1128/jb.62.3.293-300.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary DATA (6.2MB, pdf)
Supplementary Dataset 1 (117.2KB, zip)
Supplementary Dataset 2 (244.1KB, zip)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES